ID   MYO3B_HUMAN             Reviewed;        1341 AA.
AC   Q8WXR4; B8ZZR2; Q53QE1; Q53T08; Q8IX64; Q8IX65; Q8IX66; Q8IX67;
AC   Q8IX68; Q96N94;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 4.
DT   10-MAY-2017, entry version 143.
DE   RecName: Full=Myosin-IIIb;
DE            EC=2.7.11.1;
GN   Name=MYO3B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3; 4; 5 AND 6), ALTERNATIVE
RP   SPLICING, AND VARIANT LYS-1082.
RX   PubMed=11991710; DOI=10.1006/geno.2002.6749;
RA   Dose A.C., Burnside B.;
RT   "A class III myosin expressed in the retina is a potential candidate
RT   for Bardet-Biedl syndrome.";
RL   Genomics 79:621-624(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1104 (ISOFORM 7), AND
RP   VARIANTS GLU-309; ILE-770; GLY-773 AND LYS-1082.
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-21; HIS-185; SER-267; VAL-275;
RP   GLU-309; LEU-316; GLN-352; SER-388; THR-406; PRO-638; ILE-770;
RP   GLY-773; GLN-918; CYS-969; CYS-990; VAL-1092; ILE-1137 AND CYS-1165.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Probable actin-based motor with a protein kinase
CC       activity.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=MYO3B.2;
CC         IsoId=Q8WXR4-1; Sequence=Displayed;
CC       Name=2; Synonyms=MYO3B.0;
CC         IsoId=Q8WXR4-2; Sequence=VSP_010163;
CC       Name=3; Synonyms=MYO3B.1;
CC         IsoId=Q8WXR4-3; Sequence=VSP_010162, VSP_010163;
CC       Name=4; Synonyms=MYO3B.3;
CC         IsoId=Q8WXR4-4; Sequence=VSP_010162;
CC       Name=5; Synonyms=MYO3B.4;
CC         IsoId=Q8WXR4-5; Sequence=VSP_010164;
CC       Name=6; Synonyms=MYO3B.5;
CC         IsoId=Q8WXR4-6; Sequence=VSP_010165;
CC       Name=7;
CC         IsoId=Q8WXR4-7; Sequence=VSP_023111;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in retina, kidney and testis.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the TRAFAC class
CC       myosin-kinesin ATPase superfamily. Myosin family. {ECO:0000305}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the protein
CC       kinase superfamily. STE Ser/Thr protein kinase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF369908; AAL57233.1; -; mRNA.
DR   EMBL; AF391554; AAO13799.1; -; mRNA.
DR   EMBL; AF391555; AAO13800.1; -; mRNA.
DR   EMBL; AF391556; AAO13801.1; -; mRNA.
DR   EMBL; AF391557; AAO13802.1; -; mRNA.
DR   EMBL; AF391558; AAO13803.1; -; mRNA.
DR   EMBL; AC007277; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC012594; AAY24324.1; -; Genomic_DNA.
DR   EMBL; AC068280; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093402; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC114794; AAY24159.1; -; Genomic_DNA.
DR   EMBL; AK055778; BAB71011.1; -; mRNA.
DR   CCDS; CCDS42773.1; -. [Q8WXR4-1]
DR   CCDS; CCDS46446.1; -. [Q8WXR4-4]
DR   RefSeq; NP_001077084.2; NM_001083615.3. [Q8WXR4-4]
DR   RefSeq; NP_620482.3; NM_138995.4. [Q8WXR4-1]
DR   RefSeq; XP_006712362.1; XM_006712299.3. [Q8WXR4-7]
DR   UniGene; Hs.671900; -.
DR   ProteinModelPortal; Q8WXR4; -.
DR   SMR; Q8WXR4; -.
DR   BioGrid; 126621; 3.
DR   IntAct; Q8WXR4; 4.
DR   STRING; 9606.ENSP00000386213; -.
DR   BindingDB; Q8WXR4; -.
DR   ChEMBL; CHEMBL5654; -.
DR   GuidetoPHARMACOLOGY; 2113; -.
DR   iPTMnet; Q8WXR4; -.
DR   PhosphoSitePlus; Q8WXR4; -.
DR   BioMuta; MYO3B; -.
DR   DMDM; 296439486; -.
DR   MaxQB; Q8WXR4; -.
DR   PaxDb; Q8WXR4; -.
DR   PeptideAtlas; Q8WXR4; -.
DR   PRIDE; Q8WXR4; -.
DR   Ensembl; ENST00000317935; ENSP00000314650; ENSG00000071909. [Q8WXR4-3]
DR   Ensembl; ENST00000408978; ENSP00000386213; ENSG00000071909. [Q8WXR4-1]
DR   Ensembl; ENST00000409044; ENSP00000386497; ENSG00000071909. [Q8WXR4-4]
DR   GeneID; 140469; -.
DR   KEGG; hsa:140469; -.
DR   UCSC; uc002ufy.4; human. [Q8WXR4-1]
DR   CTD; 140469; -.
DR   DisGeNET; 140469; -.
DR   GeneCards; MYO3B; -.
DR   H-InvDB; HIX0002580; -.
DR   HGNC; HGNC:15576; MYO3B.
DR   HPA; HPA015745; -.
DR   HPA; HPA045483; -.
DR   MIM; 610040; gene.
DR   neXtProt; NX_Q8WXR4; -.
DR   OpenTargets; ENSG00000071909; -.
DR   PharmGKB; PA31406; -.
DR   eggNOG; KOG0587; Eukaryota.
DR   eggNOG; KOG4229; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   GeneTree; ENSGT00840000129687; -.
DR   HOVERGEN; HBG052555; -.
DR   InParanoid; Q8WXR4; -.
DR   KO; K08834; -.
DR   OMA; HWVLGKT; -.
DR   OrthoDB; EOG091G00C2; -.
DR   PhylomeDB; Q8WXR4; -.
DR   TreeFam; TF326512; -.
DR   SignaLink; Q8WXR4; -.
DR   ChiTaRS; MYO3B; human.
DR   GenomeRNAi; 140469; -.
DR   PRO; PR:Q8WXR4; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000071909; -.
DR   ExpressionAtlas; Q8WXR4; baseline and differential.
DR   Genevisible; Q8WXR4; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0016459; C:myosin complex; IEA:UniProtKB-KW.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003774; F:motor activity; IEA:InterPro.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0050896; P:response to stimulus; IEA:UniProtKB-KW.
DR   GO; GO:0007601; P:visual perception; IEA:UniProtKB-KW.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00612; IQ; 1.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 2.
DR   SMART; SM00242; MYSc; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50096; IQ; 2.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   2: Evidence at transcript level;
KW   Actin-binding; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Kinase; Motor protein; Myosin;
KW   Nucleotide-binding; Polymorphism; Reference proteome; Repeat;
KW   Sensory transduction; Serine/threonine-protein kinase; Transferase;
KW   Vision.
FT   CHAIN         1   1341       Myosin-IIIb.
FT                                /FTId=PRO_0000086415.
FT   DOMAIN       27    293       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      343   1058       Myosin motor.
FT   DOMAIN     1060   1089       IQ 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   DOMAIN     1087   1116       IQ 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00116}.
FT   NP_BIND      33     41       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    156    156       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      56     56       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   VAR_SEQ       1      1       M -> MLQSALLSTR (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_023111.
FT   VAR_SEQ    1097   1123       Missing (in isoform 3 and isoform 4).
FT                                {ECO:0000303|PubMed:11991710}.
FT                                /FTId=VSP_010162.
FT   VAR_SEQ    1193   1341       HSQAQSSPKGCDIFAGHANKHSVSGTDLLSSRICHPAPDQQ
FT                                GLSLWGAPQKPGSENGLAQKHRTPRRRCQQPKMLSSPEDTM
FT                                YYNQLNGTLEYQGSKRKPRKLGQIKVLDGEDEYYKSLSPVD
FT                                CIPEENNSAHPSFFSSSSKGDSFAQH -> WSFTLLLRLEC
FT                                NSMISADCNLRPLGSSDSPASASRVAGITGIHKPRVLQKGA
FT                                ISSQDMQTSTRFLGLICCLLGYAILLQISKD (in
FT                                isoform 5).
FT                                {ECO:0000303|PubMed:11991710}.
FT                                /FTId=VSP_010164.
FT   VAR_SEQ    1193   1341       Missing (in isoform 6).
FT                                {ECO:0000303|PubMed:11991710}.
FT                                /FTId=VSP_010165.
FT   VAR_SEQ    1245   1341       GSENGLAQKHRTPRRRCQQPKMLSSPEDTMYYNQLNGTLEY
FT                                QGSKRKPRKLGQIKVLDGEDEYYKSLSPVDCIPEENNSAHP
FT                                SFFSSSSKGDSFAQH -> AFPHYGCNFYGFRKWSCTEASN
FT                                TSPTMSAAQNAE (in isoform 2 and isoform
FT                                3). {ECO:0000303|PubMed:11991710}.
FT                                /FTId=VSP_010163.
FT   VARIANT      21     21       P -> S (in dbSNP:rs35391761).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040886.
FT   VARIANT     185    185       R -> H (in dbSNP:rs55911154).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040887.
FT   VARIANT     267    267       N -> S (in dbSNP:rs34509373).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040888.
FT   VARIANT     275    275       I -> V (in dbSNP:rs10209102).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_030605.
FT   VARIANT     309    309       K -> E (in dbSNP:rs4668246).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_030606.
FT   VARIANT     316    316       H -> L (in dbSNP:rs55633190).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040889.
FT   VARIANT     352    352       E -> Q (in dbSNP:rs56179904).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040890.
FT   VARIANT     388    388       N -> S (in dbSNP:rs34273653).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040891.
FT   VARIANT     406    406       A -> T (in dbSNP:rs10168181).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_030607.
FT   VARIANT     638    638       Q -> P (in dbSNP:rs55911627).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040892.
FT   VARIANT     770    770       V -> I (in dbSNP:rs6736609).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_030608.
FT   VARIANT     773    773       E -> G (in dbSNP:rs33962844).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040893.
FT   VARIANT     798    798       E -> K (in dbSNP:rs11892763).
FT                                /FTId=VAR_030609.
FT   VARIANT     918    918       R -> Q (in dbSNP:rs55769829).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040894.
FT   VARIANT     969    969       S -> C (in dbSNP:rs35857918).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040895.
FT   VARIANT     990    990       R -> C (in dbSNP:rs34236931).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040896.
FT   VARIANT    1082   1082       R -> K (in dbSNP:rs10185178).
FT                                {ECO:0000269|PubMed:11991710,
FT                                ECO:0000269|PubMed:14702039}.
FT                                /FTId=VAR_030610.
FT   VARIANT    1092   1092       I -> V (in dbSNP:rs34219776).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040897.
FT   VARIANT    1137   1137       V -> I (in dbSNP:rs34546065).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040898.
FT   VARIANT    1165   1165       R -> C (in dbSNP:rs56052422).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040899.
FT   CONFLICT    261    261       K -> R (in Ref. 3; BAB71011).
FT                                {ECO:0000305}.
FT   CONFLICT    573    573       T -> A (in Ref. 3; BAB71011).
FT                                {ECO:0000305}.
FT   CONFLICT    870    870       K -> M (in Ref. 1; AAL57233/AAO13799/
FT                                AAO13800/AAO13801/AAO13802/AAO13803).
FT                                {ECO:0000305}.
FT   CONFLICT   1081   1081       K -> N (in Ref. 3; BAB71011).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1341 AA;  151829 MW;  76F84C571DAA269D CRC64;
     MKHLYGLFHY NPMMLGLESL PDPTDTWEII ETIGKGTYGK VYKVTNKRDG SLAAVKILDP
     VSDMDEEIEA EYNILQFLPN HPNVVKFYGM FYKADHCVGG QLWLVLELCN GGSVTELVKG
     LLRCGQRLDE AMISYILYGA LLGLQHLHNN RIIHRDVKGN NILLTTEGGV KLVDFGVSAQ
     LTSTRLRRNT SVGTPFWMAP EVIACEQQYD SSYDARCDVW SLGITAIELG DGDPPLFDMH
     PVKTLFKIPR NPPPTLLHPE KWCEEFNHFI SQCLIKDFER RPSVTHLLDH PFIKGVHGKV
     LFLQKQLAKV LQDQKHQNPV AKTRHERMHT RRPYHVEDAE KYCLEDDLVN LEVLDEDTII
     HQLQKRYADL LIYTYVGDIL IALNPFQNLS IYSPQFSRLY HGVKRASNPP HIFASADAAY
     QCMVTLSKDQ CIVISGESGS GKTESAHLIV QHLTFLGKAN NQTLREKILQ VNSLVEAFGN
     SCTAINDNSS RFGKYLEMMF TPTGVVMGAR ISEYLLEKSR VIKQAAREKN FHIFYYIYAG
     LHHQKKLSDF RLPEEKPPRY IADETGRVMH DITSKESYRR QFEAIQHCFR IIGFTDKEVH
     SVYRILAGIL NIGNIEFAAI SSQHQTDKSE VPNAEALQNA ASVLCISPEE LQEALTSHCV
     VTRGETIIRA NTVDRAADVR DAMSKALYGR LFSWIVNRIN TLLQPDENIC SAGGGMNVGI
     LDIFGFENFQ RNSFEQLCIN IANEQIQYYF NQHVFALEQM EYQNEGIDAV PVEYEDNRPL
     LDMFLQKPLG LLALLDEESR FPQATDQTLV DKFEDNLRCK YFWRPKGVEL CFGIQHYAGK
     VLYDASGVLE KNRDTLPADV VVVLRTSENK LLQQLFSIPL TKTGNLAQTR ARITVASSSL
     PPHFSAGKAK VDTLEVIRHP EETTNMKRQT VASYFRYSLM DLLSKMVVGQ PHFVRCIKPN
     DDREALQFSR ERVLAQLRST GILETVSIRR QGYSHRILFE EFVKRYYYLA FTAHQTPLAS
     KESCVAILEK SRLDHWVLGK TKVFLKYYHV EQLNLLLREV IGRVVVLQAY TKGWLGARRY
     KRVREKREKG AIAIQSAWRG YDARRKFKKI SNRRNESAAH NQAGDTSNQS SGPHSPVAAG
     TRGSAEVQDC SEPGDHKVLR GSVHRRSHSQ AESNNGRTQT SSNSPAVTEK NGHSQAQSSP
     KGCDIFAGHA NKHSVSGTDL LSSRICHPAP DQQGLSLWGA PQKPGSENGL AQKHRTPRRR
     CQQPKMLSSP EDTMYYNQLN GTLEYQGSKR KPRKLGQIKV LDGEDEYYKS LSPVDCIPEE
     NNSAHPSFFS SSSKGDSFAQ H
//
